206 related articles for article (PubMed ID: 15068244)
1. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
[TBL] [Abstract][Full Text] [Related]
2. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
3. Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5).
Ferrando-Miguel R; Cheon MS; Lubec G
Amino Acids; 2004 Jun; 26(3):255-61. PubMed ID: 15221505
[TBL] [Abstract][Full Text] [Related]
4. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
5. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV).
Cheon MS; Shim KS; Kim SH; Hara A; Lubec G
Amino Acids; 2003 Jul; 25(1):41-7. PubMed ID: 12836057
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease.
Pollak D; Cairns N; Lubec G
J Neural Transm Suppl; 2003; (67):149-58. PubMed ID: 15068247
[TBL] [Abstract][Full Text] [Related]
7. Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.
Wilcock DM; Griffin WS
J Neuroinflammation; 2013 Jul; 10():84. PubMed ID: 23866266
[TBL] [Abstract][Full Text] [Related]
8. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
[TBL] [Abstract][Full Text] [Related]
9. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
[TBL] [Abstract][Full Text] [Related]
10. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
11. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.
Sun X; Wu Y; Chen B; Zhang Z; Zhou W; Tong Y; Yuan J; Xia K; Gronemeyer H; Flavell RA; Song W
J Biol Chem; 2011 Mar; 286(11):9049-62. PubMed ID: 21216952
[TBL] [Abstract][Full Text] [Related]
12. Expression of trisomic proteins in Down syndrome model systems.
Spellman C; Ahmed MM; Dubach D; Gardiner KJ
Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
[TBL] [Abstract][Full Text] [Related]
13. [Cell-cycle negative regulatory gene ANA is over-expressed in the brain tissues of patients with Down syndrome].
He XJ; Zhang Q; Ma LP; Yang LJ; Shen H; Guo JZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):608-11. PubMed ID: 16378112
[TBL] [Abstract][Full Text] [Related]
14. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
15. Neuronal apoptosis inhibitory protein (NAIP)-like immunoreactivity in brains of adult patients with Down syndrome.
Seidl R; Bajo M; Böhm K; LaCasse EC; MacKenzie AE; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():283-91. PubMed ID: 10666683
[TBL] [Abstract][Full Text] [Related]
16. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.
Shim KS; Lubec G
Neurosci Lett; 2002 May; 324(3):209-12. PubMed ID: 12009525
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of transcription factor BACH1 in fetal Down syndrome brain.
Ferrando-Miguel R; Cheon MS; Yang JW; Lubec G
J Neural Transm Suppl; 2003; (67):193-205. PubMed ID: 15068251
[TBL] [Abstract][Full Text] [Related]
19. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
Cheon MS; Dierssen M; Kim SH; Lubec G
Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
